Swiss Capital – Brokerul Tău pe Piața de Capital
  • News
  • Research
  • About Us
  • Why Should I Invest?
  • English
    • Română
    • English

File Type: pdf

ATB RO: Q4 2025 Earnings preview

by Stoian Cosmin 02/25/2026

* Antibiotice is scheduled to report Q4/FY 2025 results on February 26. * For Q4, we expect a net loss of RON 6.8m versus a net profit of RON 14.3m in Q4 2024, primarily driven by weaker revenues. Sales are …

Continue Reading
02/25/2026

SNN RO: Q4 2025 Earnings preview

by Stoian Cosmin 02/25/2026

* Nuclearelectrica is scheduled to publish its preliminary Q4 / FY 2025 IFRS individual results on February 27th. * We forecast Q4 2025 net profit at RON 687m, up 62% Y/Y, the improvement being primarily attributable to the absence of …

Continue Reading
02/25/2026

TLV RO: Q4 2025 Earnings preview

by Stoian Cosmin 02/25/2026

* Banca Transilvania is due to release Q4/FY 2025 results on February 27. * At the IFRS individual level, we expect Q4 net profit at RON 1,080m, up 31% Y/Y, supported by stronger core, trading and dividend income, more than …

Continue Reading
02/25/2026

TTS RO: Q4 2025 Earnings preview

by Stoian Cosmin 02/25/2026

* Transport Trade Services will publish preliminary Q4 / FY 2025 results on the 27th of February. * In Q4 2025, TTS is expected to report a net loss of RON 1m, compared to a loss of RON 8m in Q4’24, …

Continue Reading
02/25/2026

ONE RO: Q4 2025 Earnings preview

by Stoian Cosmin 02/25/2026

* One United Properties will release its preliminary Q4 / FY 2025 results on February 27. * We forecast ONE to deliver a Q4 2025 net profit of RON 66m, down 11% Y/Y from RON 74m in Q4 2024, mainly …

Continue Reading
02/25/2026
Newer Posts
Older Posts
Swiss Capital – Brokerul Tău pe Piața de Capital
  • News
  • Research
  • About Us
  • Why Should I Invest?
  • English
    • Română
    • English
Investments on the capital market involve risks, and before making the decision to invest, it is necessary to consider the financial objectives, the level of experience and the appetite for risk. The analyses, studies, opinions, news, prices or any other information available on the site do not constitute trading recommendations. The content of the website can be changed without prior notice

© 2011-2026 Swiss Capital -All rights reservedDeveloped by HyperSense-Software